Two experts in obesity medicine discuss the latest advances in obesity care, including:

  • Current data for incretin-based therapies
  • Beyond the scale—individualizing OMM selection based on weight-related comorbidities and cardiometabolic risk
  • Common contraindications and warnings associated with certain OMMs
  • Shared decision-making strategies to inform treatment selection.

[JF1]Added this to the episode notes to maybe help with the posttest 

Presenters
Amy Butts, PA-C, DFAAPA, BC-ADM, CDCES
Endocrine Physician Associate
WVU Medicine Wheeling Hospital
Immediate Past President of American Society of Endocrine Physician Associates
Wellsburg, West Virginia

Nicholas Pennings, DO
Professor of Family Medicine
Campbell University School of Osteopathic Medicine
Director of Clinical Education
Obesity Medicine Association
Buies Creek, North Carolina

Link to full program:
https://bit.ly/4v7eIY4

Get access to all of our new podcasts by subscribing to the Decera Clinical Education Multispecialty Podcast on Apple Podcasts, YouTube Music, or Spotify.


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Podden och tillhörande omslagsbild på den här sidan tillhör Decera Clinical Education. Innehållet i podden är skapat av Decera Clinical Education och inte av, eller tillsammans med, Poddtoppen.